Abstract
The in vivo experiments show that the adenosylcobalamin cofactor in glutamate mutase and methylmalonyl-CoA mutase processes lose its dimethylbenzimidazole axial ligand before starting the enzymatic processes. Complete active space self-consistent field geometry optimization of the vitamin B12 active forms plus substrates joint models have been performed. These joint models include the adenosylcobalamin cofactor, the carboxyl negative ion model of the studied processes’ active substrates, and the histidine molecule. Partial electronic density is transferred from the highest occupied substrate molecular orbitals to the lowest unoccupied antibonding molecular orbitals, which consist of corrin ring and dimethylbenzimidazole ligand common molecular orbitals during the multi-configurational self-consistent field molecular orbital mixing process. As a result, the Co-N axial bond is permanently elongated during the complete active space self-consistent field geometry optimization until its complete rupture and until the removal of the dimethylbenzimidazole ligand from the central cobalt atom and the corrin ring is complete. The Co-N bond cleavage in the adenosylcobalamin cofactors in the studied processes is running as no energy barrier process under the influence of their active substrates and histidine molecule.
Subject
Process Chemistry and Technology,Environmental Chemistry,General Chemistry
Reference40 articles.
1. 1. Sigel, A.; Sigel, H.; Sigel, R.K.O. Eds. Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. Springer: Berlin, 2013, 13, pp. 295-320. DOI: https://doi.org/10.1007/978-94-007-7500-8
2. 2. Wald, I.; Członkowska, A.; Dowżenko, A. Clinical Neurology. Warsaw: National Institute of Medical Publications, 1987, 451 p. (in Polish) https://allegrolokalnie.pl/oferta/neurologiakliniczna-wald-dowzenko-czlonkowska
3. 3. Morris, M.C.; Evans, D.A.; Schneider, J.A.; Tangney, C.C.; Bienias, J.L.; Aggarwal, N.T.Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. Journal of Alzheimer's Disease, 2006, 9(4),pp. 435-443.DOI: https://doi.org/10.3233/jad-2006-9410
4. 4. Kivipelto, M.; Annerbo, S.; Hultdin, J.; Bäckman, L.; Viitanen, M.; Fratiglioni, L.; Lökk, J. Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimer's disease: a prospective study. European Journal of Neurology, 2009, 16(7), pp. 808-813. DOI: https://doi.org/10.1111/j.1468-1331.2009.02590.x
5. 5. Prodan, C.I.; Cowan, L.D.; Stoner, J.A.; Ross, E.D. Cumulative incidence of vitamin B12 deficiency in patients with Alzheimer disease. Journal of the Neurological Sciences, 2009, 284(1-2), pp. 144-148. DOI: https://doi.org/10.1016/j.jns.2009.05.005
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献